Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner Hamburg asks for more power over non-traditional compounding to better regulate companies like the New England Compounding Center, but several House members say it looks like the agency already has the authority it needs.

You may also be interested in...



FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel